BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15705354)

  • 61. A nonsense mutation in the synaptogyrin 1 gene in a family with schizophrenia.
    Verma R; Chauhan C; Saleem Q; Gandhi C; Jain S; Brahmachari SK
    Biol Psychiatry; 2004 Jan; 55(2):196-9. PubMed ID: 14732601
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Netrin G1: its downregulation in the nucleus accumbens of cocaine-conditioned mice and genetic association in human cocaine dependence.
    Kelaï S; Ramoz N; Moalic JM; Noble F; Mechawar N; Imbeaud S; Turecki G; Simonneau M; Gorwood P; Maussion G
    Addict Biol; 2018 Jan; 23(1):448-460. PubMed ID: 28074533
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Positive selection within the Schizophrenia-associated GABA(A) receptor beta(2) gene.
    Lo WS; Xu Z; Yu Z; Pun FW; Ng SK; Chen J; Tong KL; Zhao C; Xu X; Tsang SY; Harano M; Stöber G; Nimgaonkar VL; Xue H
    PLoS One; 2007 May; 2(5):e462. PubMed ID: 17520021
    [TBL] [Abstract][Full Text] [Related]  

  • 64. NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences.
    Atz ME; Rollins B; Vawter MP
    Psychiatr Genet; 2007 Apr; 17(2):55-67. PubMed ID: 17413444
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy.
    Friedman JI; Vrijenhoek T; Markx S; Janssen IM; van der Vliet WA; Faas BH; Knoers NV; Cahn W; Kahn RS; Edelmann L; Davis KL; Silverman JM; Brunner HG; van Kessel AG; Wijmenga C; Ophoff RA; Veltman JA
    Mol Psychiatry; 2008 Mar; 13(3):261-6. PubMed ID: 17646849
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Functional genomics in postmortem human brain: abnormalities in a DISC1 molecular pathway in schizophrenia.
    Lipska BK; Mitkus SN; Mathew SV; Fatula R; Hyde TM; Weinberger DR; Kleinman JE
    Dialogues Clin Neurosci; 2006; 8(3):353-7. PubMed ID: 17117617
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies.
    Hirata Y; Zai CC; Souza RP; Lieberman JA; Meltzer HY; Kennedy JL
    Hum Psychopharmacol; 2012 Jul; 27(4):345-51. PubMed ID: 22730074
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of Ca²⁺-dependent activator protein for secretion 2 is increased in the brains of schizophrenic patients.
    Hattori K; Tanaka H; Wakabayashi C; Yamamoto N; Uchiyama H; Teraishi T; Hori H; Arima K; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1738-43. PubMed ID: 21601610
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk variants in the S100B gene, associated with elevated S100B levels, are also associated with visuospatial disability of schizophrenia.
    Zhai J; Zhang Q; Cheng L; Chen M; Wang K; Liu Y; Deng X; Chen X; Shen Q; Xu Z; Ji F; Liu C; Dong Q; Chen C; Li J
    Behav Brain Res; 2011 Mar; 217(2):363-8. PubMed ID: 21070816
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An investigation of the dihydropyrimidinase-like 2 (DPYSL2) gene in schizophrenia: genetic association study and expression analysis.
    Zhao X; Tang R; Xiao Z; Shi Y; Feng G; Gu N; Shi J; Xing Y; Yan L; Sang H; Zhu S; Liu H; Chen W; Liu J; Tang W; Zhang J; He L
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):705-12. PubMed ID: 16321170
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.
    Håvik B; Le Hellard S; Rietschel M; Lybæk H; Djurovic S; Mattheisen M; Mühleisen TW; Degenhardt F; Priebe L; Maier W; Breuer R; Schulze TG; Agartz I; Melle I; Hansen T; Bramham CR; Nöthen MM; Stevens B; Werge T; Andreassen OA; Cichon S; Steen VM
    Biol Psychiatry; 2011 Jul; 70(1):35-42. PubMed ID: 21439553
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder.
    Wong AH; Likhodi O; Trakalo J; Yusuf M; Sinha A; Pato CN; Pato MT; Van Tol HH; Kennedy JL
    Schizophr Res; 2005 Oct; 78(2-3):137-46. PubMed ID: 16054338
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia.
    Mukai J; Liu H; Burt RA; Swor DE; Lai WS; Karayiorgou M; Gogos JA
    Nat Genet; 2004 Jul; 36(7):725-31. PubMed ID: 15184899
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential expression of disrupted-in-schizophrenia (DISC1) in bipolar disorder.
    Maeda K; Nwulia E; Chang J; Balkissoon R; Ishizuka K; Chen H; Zandi P; McInnis MG; Sawa A
    Biol Psychiatry; 2006 Nov; 60(9):929-35. PubMed ID: 16814263
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Replication of NTNG1 association in schizophrenia.
    Wilcox JA; Quadri S
    Psychiatr Genet; 2014 Dec; 24(6):266-8. PubMed ID: 25325217
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human QKI, a new candidate gene for schizophrenia involved in myelination.
    Aberg K; Saetre P; Lindholm E; Ekholm B; Pettersson U; Adolfsson R; Jazin E
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jan; 141B(1):84-90. PubMed ID: 16342280
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exomic sequencing of the ionotropic glutamate receptor N-methyl-D-aspartate 3A gene (GRIN3A) reveals no association with schizophrenia.
    Shen YC; Liao DL; Chen JY; Wang YC; Lai IC; Liou YJ; Chen YJ; Luu SU; Chen CH
    Schizophr Res; 2009 Oct; 114(1-3):25-32. PubMed ID: 19665356
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients.
    Morikawa T; Manabe T; Ito Y; Yamada S; Yoshimi A; Nagai T; Ozaki N; Mayeda A
    Neurochem Int; 2010; 56(6-7):736-9. PubMed ID: 20347905
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The insulin receptor substrate-4 (IRS-4) gene and schizophrenia: no evidence for a main genetic factor, however one report of a single schizophrenia patient with a mutation.
    Melkersson K; Persson B; Hongslo T
    Neuro Endocrinol Lett; 2011; 32(1):52-8. PubMed ID: 21407155
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3'-UTR.
    Novak G; Tallerico T
    Brain Res; 2006 Nov; 1120(1):161-71. PubMed ID: 17022955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.